US 10603311
Use of pridopidine to improve cognitive function and for treating Alzheimer's disease
granted A61KA61K31/451A61P
Quick answer
US patent 10603311 (Use of pridopidine to improve cognitive function and for treating Alzheimer's disease) held by The Board of Regents of the University of Texas System expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/451, A61P, A61P25/22, A61P25/24